Less than 8 percent of respondents to a research study of clinical trial participants felt that the potential negative consequences of data sharing outweighed the benefits.
Nearly half of consumers have abandoned a medication prescribed by their physician because it was too expensive, according to a survey by DrFirst, a provider of e-prescribing and patient medication management solutions.
Recent data suggests that less than one in five pharma marketers are very satisfied with their digital activities.
Patients affiliated with physicians in Humana MA value-based agreements had more favorable outcomes in all Healthcare Effectiveness Data and Information Set (HEDIS) Star measures in 2017, according to Humana’s “The intersection of health + care” value-based care report.
A survey profiling how American adults access, use, and feel about health-related information found that most American social media users who regularly seek health information are concerned about incorrect or misleading medical information on social media, and few have found health information on social media to be accurate.
Northwest Physicians Network – a subsidiary of DaVita Inc. DVA – launched a collaborative program with various medical and community service groups in Pierce County, Washington that has led to a significant reduction in emergency services such as 911 calls, ambulance transports, and hospital admissions.
Express Scripts released new data showing significantly improved clinical outcomes and reduced drug spending for diabetes – one of America’s deadliest and most costly health conditions.
Join leading pharmaceutical companies across the United States for a live webinar, complete with live Q&A from experts, exploring “Anti-Drug Antibody Assay Validation, An Industry Perspective.”
Intra-Cellular Therapies Inc. announced that the U.S. Food and Drug Administration accepted for review the biopharmaceutical company’s New Drug Application for lumateperone, an investigational agent for the treatment of schizophrenia.
For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.